Skip to main content
NCBI home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2001 May;51(466):347–348.

Hereditary haemochromatosis: never seen a case?

J Emery, P Rose
PMCID: PMC1313995  PMID: 11360695

Full Text

The Full Text of this article is available as a PDF (43.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium. Gut. 1997 Dec;41(6):841–844. doi: 10.1136/gut.41.6.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams P. C. Population screening for hemochromatosis. Hepatology. 1999 Apr;29(4):1324–1327. doi: 10.1002/hep.510290425. [DOI] [PubMed] [Google Scholar]
  3. Bhavnani M., Lloyd D., Bhattacharyya A., Marples J., Elton P., Worwood M. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut. 2000 May;46(5):707–710. doi: 10.1136/gut.46.5.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bomford A., Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med. 1976 Oct;45(180):611–623. [PubMed] [Google Scholar]
  5. Bonsor R., Gibbs T., Woodward R. Vocational training and beyond--listening to voices from a void. Br J Gen Pract. 1998 Jan;48(426):915–918. [PMC free article] [PubMed] [Google Scholar]
  6. Bradley L. A., Haddow J. E., Palomaki G. E. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3(4):178–184. doi: 10.1177/096914139600300404. [DOI] [PubMed] [Google Scholar]
  7. Burke W., Thomson E., Khoury M. J., McDonnell S. M., Press N., Adams P. C., Barton J. C., Beutler E., Brittenham G., Buchanan A. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998 Jul 8;280(2):172–178. doi: 10.1001/jama.280.2.172. [DOI] [PubMed] [Google Scholar]
  8. Calnan M., Katsouyiannopoulos V., Ovcharov V. K., Prokhorskas R., Ramic H., Williams S. Major determinants of consumer satisfaction with primary care in different health systems. Fam Pract. 1994 Dec;11(4):468–478. doi: 10.1093/fampra/11.4.468. [DOI] [PubMed] [Google Scholar]
  9. Elwyn G. J., Smail S. A., Edwards A. G. Is general practice in need of a career structure? BMJ. 1998 Sep 12;317(7160):730–733. doi: 10.1136/bmj.317.7160.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Jr, Ellis M. C., Fullan A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar]
  11. Frayling T., Ellard S., Grove J., Walker M., Hattersley A. T. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet. 1998 Jun 27;351(9120):1933–1934. doi: 10.1016/S0140-6736(05)78618-9. [DOI] [PubMed] [Google Scholar]
  12. Haddow J. E., Bradley L. A. Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ. 1999 Aug 28;319(7209):531–532. doi: 10.1136/bmj.319.7209.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heath I., Evans P., van Weel C. The specialist of the discipline of general practice. Semantics and politics mustn't impede the progress of general practice. BMJ. 2000 Feb 5;320(7231):326–327. doi: 10.1136/bmj.320.7231.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johnson N., Hasler J., Hayden J., Mathie T., Dobbie W. The career outcomes for doctors completing general practice vocational training 1990-1995. Br J Gen Pract. 1998 Nov;48(436):1755–1758. [PMC free article] [PubMed] [Google Scholar]
  15. Kearley K. An evaluation of the hospital component of general practice vocational training. Br J Gen Pract. 1990 Oct;40(339):409–414. [PMC free article] [PubMed] [Google Scholar]
  16. Low L., King S., Wilkie T. Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom. BMJ. 1998 Dec 12;317(7173):1632–1635. doi: 10.1136/bmj.317.7173.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McDonnell S. M., Preston B. L., Jewell S. A., Barton J. C., Edwards C. Q., Adams P. C., Yip R. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med. 1999 Jun;106(6):619–624. doi: 10.1016/s0002-9343(99)00120-5. [DOI] [PubMed] [Google Scholar]
  18. Merryweather-Clarke A. T., Pointon J. J., Shearman J. D., Robson K. J. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997 Apr;34(4):275–278. doi: 10.1136/jmg.34.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Niederau C., Fischer R., Pürschel A., Stremmel W., Häussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996 Apr;110(4):1107–1119. doi: 10.1053/gast.1996.v110.pm8613000. [DOI] [PubMed] [Google Scholar]
  20. Niederau C., Niederau C. M., Lange S., Littauer A., Abdel-Jalil N., Maurer M., Häussinger D., Strohmeyer G. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med. 1998 Mar 1;128(5):337–345. doi: 10.7326/0003-4819-128-5-199803010-00001. [DOI] [PubMed] [Google Scholar]
  21. Phatak P. D., Guzman G., Woll J. E., Robeson A., Phelps C. E. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 1994 Apr 11;154(7):769–776. [PubMed] [Google Scholar]
  22. Phatak P. D., Sham R. L., Raubertas R. F., Dunnigan K., O'Leary M. T., Braggins C., Cappuccio J. D. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med. 1998 Dec 1;129(11):954–961. doi: 10.7326/0003-4819-129-11_part_2-199812011-00006. [DOI] [PubMed] [Google Scholar]
  23. Salonen J. T., Tuomainen T. P., Kontula K. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. BMJ. 2000 Jun 24;320(7251):1706–1707. doi: 10.1136/bmj.320.7251.1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Seamark C. J., Hutchinson M. Controversy in primary care: Should asymptomatic haemochromatosis be treated? BMJ. 2000 May 13;320(7245):1314–1317. doi: 10.1136/bmj.320.7245.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tuomainen T. P., Kontula K., Nyyssönen K., Lakka T. A., Heliö T., Salonen J. T. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation. 1999 Sep 21;100(12):1274–1279. doi: 10.1161/01.cir.100.12.1274. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES